No Data
No Data
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Beam Therapeutics Inc. (NASDAQ:BEAM) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Beam Therapeutics Gains as H.C. Wainwright Starts at Buy
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Express News | Beam Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced an $80 Price Target
No Data